Moderna
Page 5 of 18
By Fiona Rutherford and BloombergJanuary 21, 2022

By James Paton and BloombergJanuary 14, 2022

HealthPushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022

By Andrew MarquardtJanuary 10, 2022

By Low De Wei and BloombergJanuary 10, 2022

By Erika Fry and Nicolas RappJanuary 5, 2022

By Jeremy KahnDecember 29, 2021

HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021

HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021

By Suzi Ring, Naomi Kresge and BloombergDecember 20, 2021

HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021

By Lauran Neergaard, Mike Stobbe and The Associated PressDecember 16, 2021

By Christiaan HetznerDecember 16, 2021

By Erika Fry and Nicolas RappDecember 15, 2021
Most Popular



